WASHINGTON (dpa-AFX) - Biotechnology stocks have shown a significant move to the downside during trading on Tuesday, dragging the NYSE Arca Biotechnology Index down by 1.8 percent.
Illumina (ILMN) has helped to lead the sector lower, plunging by 23.6 percent after warning of weaker than expected first quarter revenue.
Myriad Genetics (MYGN) and Celldex Therapeutics (CLDX) are also posting notable losses, slumping by 7.6 percent and 6.1 percent, respectively.
Copyright RTT News/dpa-AFX